A Phase I, Open-label study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV dose of [14C]AZD9291

Trial Identifier:	D5160C00020
Sponsor:	AstraZeneca
NCTID::	NCT02491944
Start Date:	July 2015
Primary Completion Date:	August 2015
Study Completion Date:	August 2015
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Nottingham, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.